AGP Picks
View all

The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

Press releases published on October 30, 2026

5 Star Garage Doors MA Shares Six Winter Warning Signs for Winchester Homeowners
Rocket Alumni Solutions Outlines How Schools Can Budget for and Launch a Digital Athletic Hall of Fame
TalentSheets Relaunches Influencer Campaign Management Inside Google Sheets
First Response Restoration Highlights Services and Winter Preparedness
Morphisec Issues Critical Advisory on Trojanized Claude Code Extension Targeting Developer Endpoints
Rocket Alumni Solutions Outlines Planning Priorities for College Recognition Displays
IntervalZero Announces MaxRT vRTOS 1.0, Expanding Its Real-Time Platform for Industrial Control Systems
Overtake Marketing Study: Two in Three AI-Named Roofers Miss Google Maps Top 10
Cummings Properties Named Best Flex & R&D Space Options in Woburn, MA for 2026
UniFirst Declares Increased Cash Dividends
Boston Harbor Auctions Announces November 7 Nautical Antiques Auction Featuring British Royal Navy Artifacts
Great Elm Capital Corp. (“GECC”) Schedules Third Quarter 2026 Earnings Release and Conference Call
CACC ALERT: Credit Acceptance Investigated for Securities Fraud by Block & Leviton; Investors with Losses Should Contact the Firm
RDDT INVESTIGATION: Reddit Investors Should Contact Block & Leviton to Possibly Recover Losses
Akari Therapeutics to Highlight Novel RNA-Splicing ADC Payload Strategy at the 3rd Annual ADC Payload Summit
Werewolf Therapeutics Selected for Oral Presentation and to Present Posters at the Society for Immunotherapy of Cancer’s (SITC) 2026 Annual Meeting
Vor Bio Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Acumen Pharmaceuticals Announces Topline Results from Phase 2 ALTITUDE-AD Clinical Trial of Sabirnetug (ACU193) for the Treatment of Early Alzheimer’s Disease; Trial Did Not Meet Primary Endpoint
Fractyl Health Strengthens Revita Patent Portfolio as It Advances Toward FDA Submission and Potential Commercialization
Agios Announces New PDUFA Goal Date of February 1, 2027, for Mitapivat Sickle Cell Disease sNDA; Company Is Launch-Ready and in Labeling Discussions with FDA

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Boston Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.